Matti Annala

17.4k citations
86 papers · 13.1k · 7 hit papers · h-index 41

Impact in

    • Cancer Genomics and Diagnostics
    • Cancer, Lipids, and Metabolism
    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
  • Genetics top 0.5%
    • Glioma Diagnosis and Treatment

Papers in

Matti Annala

84 papers receiving 13.0k citations

Matti Annala's Hit Papers

Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer 2024 · 91 citations
910+4+8Years since publication10002.0k3.0k

Peers

Matti Annala
Comparison fields: 5 of 130
  • Cancer Research 4.6k
  • Genetics 2.2k
  • Pulmonary and Respiratory Medicine 5.0k
  • Oncology 2.4k
  • Molecular Biology 5.3k
Replace David Pot with:
David Pot United States
Angela G. Hadjipanayis United States
Angeliki Pantazi United States
Hoon Kim United States
Brenda Ayala United States
Rahulsimham Vegesna United States
Amie Radenbaugh United States
John Sanborn United States
Christopher M. McPherson United States
Dora C. Dias-Santagata United States
Matti Annala relative to David Pot United States David Pot's profile →
Citations per field
00.5×1.5×
David Pot · 1×
Citations per year

Countries citing papers authored by Matti Annala

Since Specialization
Citations

This map shows the geographic impact of Matti Annala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matti Annala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matti Annala more than expected).

Fields of papers citing papers by Matti Annala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matti Annala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matti Annala. The network helps show where Matti Annala may publish in the future.

Co-authors

The 25 scholars most cited alongside Matti Annala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matti Annala Line = papers co-authored together Matti Annala links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Somatic Genomic Landscape of Glioblastoma
Hit paper breakdown →
20133977
2
The Molecular Taxonomy of Primary Prostate Cancer
Hit paper breakdown →
20152435
3
The evolutionary history of lethal metastatic prostate cancer
Hit paper breakdown →
20151097
4
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
Hit paper breakdown →
2018434
5 2017342
6 2013336
7
Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer
Hit paper breakdown →
2016304
8 2013288
9
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial
Hit paper breakdown →
2019271
10 2017237
11 2017195
12 2013190
13 2014171
14 2019158
15 2017138
16 2021135
17 2022134
18 2018130
19 2013111
20 2019101

About Matti Annala

Matti Annala is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Genetics, having authored 86 papers that have together received 13.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (39 papers), Cancer Genomics and Diagnostics (24 papers), Bladder and Urothelial Cancer Treatments (9 papers), Prostate Cancer Diagnosis and Treatment (8 papers), Epigenetics and DNA Methylation (5 papers), MicroRNA in disease regulation (4 papers), Genomics and Chromatin Dynamics (4 papers) and Glioma Diagnosis and Treatment (4 papers). The work is most often cited by research in Cancer Research (4.6k citations), Genetics (2.2k citations), Pulmonary and Respiratory Medicine (5.0k citations), Oncology (2.4k citations) and Molecular Biology (5.3k citations). Matti Annala has collaborated with scholars based in Finland, Canada and United States. Frequent co-authors include Matti Nykter, Alexander William Wyatt, Kim N. Chi, Kevin Beja, Martin Edwin Gleave, Gillian Rae Vandekerkhove, Evan W. Warner, Daniel Joseph Khalaf, Sinja Taavitsainen and Arun Azad. Their work appears in journals such as Annals of Oncology, Clinical Cancer Research, European Urology, Clinical Genitourinary Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact